DISABLED ENTREPRENEUR – DISABILITY UK
Disability UK Online Health Journal – All In One Business In A Box – Forum – Business Directory – Useful Resources – Health – Human Rights – Politics
DISABLED ENTREPRENEUR – DISABILITY UK
Disability UK Online Health Journal – All In One Business In A Box – Forum – Business Directory – Useful Resources – Health – Human Rights – Politics
Browsing Category
Multiple sclerosis research has produced an intriguing new development following the publication of a study involving an experimental medicine called kamuvudine-9, also known as K-9. Researchers have reported that K-9 was able not only to prevent further neurological deterioration in a laboratory model of multiple sclerosis but also to reverse existing paralysis and vision loss in mice.
Professor Tal Dvir and Tel Aviv University are developing personalised stem-cell spinal cord implants that restored walking in paralysed animals, with the first potential human treatment being prepared for 2027.
UK clinical trial reforms took effect in April 2026. Learn what they mean for experimental treatments, EAMS, patient safety and disabled people.
Living with chronic pain is an invisible battle that millions face daily. For those undergoing Personal Independence Payment (PIP) assessments in the UK, proving the extent and frequency of pain becomes yet another source of suffering. In today’s tech-driven society, there is an urgent need to develop wearable pain recognition tools, especially via mainstream devices like the Apple Watch.
Led by a team from Ludwig Maximilian University of Munich, researchers discovered that certain gut bacteria are significantly more common in people with MS—and could be directly linked to triggering the disease.
While neurostimulation holds promise as a treatment for depression, it’s essential to approach the idea of “bio-hacking” with caution. More research is needed to determine the long-term effects and ideal usage of these methods. If you or someone you know is considering neurostimulation, it’s crucial to consult with a healthcare provider to ensure safe and effective treatment.
The ability to control devices with the mind alone offers a glimpse into a future where independence is not limited by physical ability. Whether it’s restoring basic movement, enhancing communication, or simply giving people more control over their daily lives, advances like these are redefining what’s possible. As science continues to merge imagination with innovation, the line between limitation and liberation grows thinner—and the future, brighter.
The potential for psychedelic mushrooms to treat mental health disorders is becoming increasingly clear. As more research demonstrates their safety and efficacy, it is likely that psilocybin-assisted therapy will become more widely available, with doctors able to prescribe controlled doses in therapeutic settings.
If someone experiences a stroke, immediate medical intervention is crucial to save their life and minimize brain damage. There is a critical window of time, often referred to as the “golden hour,” typically within 3 to 4.5 hours from the onset of symptoms, during which treatments like clot-busting medications (such as alteplase or tenecteplase) are most effective.
SynNeurGe heralds a new era in Parkinson’s disease research, offering a comprehensive and integrated approach to understanding disease pathogenesis, stratifying patients, and developing targeted therapies.